Unveiling the significance of ADAM12 through pan-cancer analysis and experimental verification in gastric cancer

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-10-31
DOI
https://doi.org/10.1007/s12672-025-03837-w
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unveiling the significance of ADAM12 through pan-cancer analysis and experimental verification in gastric cancer

Bing‐Hua Jiang, Rui Chen, Kankan Yang
Discover Oncology
HER2/EGFR in Cancer Research
article

Unveiling the significance of ADAM12 through pan-cancer analysis and experimental verification in gastric cancer

Bing‐Hua Jiang, Rui Chen, Kankan Yang
article en

Abstract

No abstract available for this paper.
Discover OncologyVol. 16(1)
Quzhou City People's Hospital (CN), Chaohu Hospital of Anhui Medical University (CN)
Openalex Percentile: Top 57%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Unveiling the significance of ADAM12 through pan-cancer analysis and experimental verification in gastric cancer — Bing‐Hua Jiang, Rui Chen, et al. · Discover Oncology (2025) | TGRS Research Map | TGRS